已收盤 10-31 16:00:00 美东时间
+2.100
+2.06%
Biodesix will present at the 2025 AMP Annual Meeting in Boston, showcasing its R&D roadmap, strategic partnerships, and diagnostic innovations. Key partner updates will be featured in a workshop led by Dr. Gary Pestano, highlighting advancements in molecular testing for faster results, high-throughput, and efficient sample use. Biodesix will also present a poster on circulating tumor cell enrichment at the event.
10-30 10:17
The Kraft Heinz Company (NASDAQ:KHC) reported a 2.2% decline in revenue during Q3 to $6.2 billion. Organic sales fell 2.5% during the quarter to miss the consensus expectation for a drop of 2.4%. Orga...
10-29 19:27
TMTPOST -- Nvidia Corp. Is fueling the robotaxi frenzy with its latest autonomo...
10-29 17:53
(来源:市场投研资讯) 摘要 本周观点&投资建议 本周医药板块下跌2.48%,跑输沪深300指数0.26pct。板块内部来看,子板块中药店、中药、仿...
10-21 11:37
Signpost India Limited ( ($IN:SIGNPOST) ) has shared an update. Signpost India ...
10-20 01:24
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Libtayo® (cemiplimab)
10-17 19:32
USA News Group News Commentary – Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 15, 2025 /PRNewswire/ -- USA News Group News Commentary – Biomarker-driven drug development is acc...
10-15 21:11
Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.20-0.51;
10-09 02:33
In the current session, Post Holdings Inc. (NYSE:POST) is trading at $107.28, a...
10-01 22:01
TMTPOST -- This year's unprecedented eight-day "Super Golden Week" has seen a s...
09-28 10:28